inquiry@market.us
+1 718 874 1545 (International)
+91 78878 22626 (Asia)
Search...
All Reports
All Sectors
Who Trust Us
Home ➤ Life Science ➤ Pharmaceuticals ➤ Obesity Treatment Market
Global Obesity Treatment Market By Surgery Type(Adjustable gastric banding,
Roux-en-Y gastric bypass, Sleeve gastrectomy, and Others) By Drug Type
(Appetite suppressants, Combination drugs, Malabsorption drugs, Satiety drugs)
End-Use(By Hospitals, Clinics) By Region and Companies - Industry Segment
Outlook, Market Assessment, Competition Scenario, Trends and Forecast 20242033
Published date: Nov 2023
Report ID: 100211
Number of Pages: 394
Inquiry Before Buying
Mention interested
topics/company profiles.
Format:
Enter Name
Overview
Table of Contents
Major Market Players
Request a Free Sample
Enter Email ID
-Select Country-
Quick Navigation
Report Overview
The Obesity Treatment Market size is expected to be worth around USD 58.3 Billion by 2033
from USD 14.9 Billion in 2023, growing at a CAGR of 14.6% during the forecast period from 2024
Enter Phone Number
Enter Company Name
Submit
to 2033.
Obesity is the increase in excessive or abnormal fat in the body, which causes a health risk.
Obesity is linked to chronic diseases such as diabetes, orthopedic disorder, high blood
pressure, and cancer. The growing rate of overweight individuals is responsible for the spread
of chronic diseases.
Report ID
Weight management programs and the increase in government initiatives targeting obesity’s
Published Date
harmful health effects are driving demand for technologically advanced weight-loss
equipment, while flourishing gym culture, cosmetic concerns among millennials, weight-loss
surgery as a method for treating excess body mass index (BMI), healthcare cost increases
present opportunities to grow the global market further.
World Health Organization (WHO) defines overweight and obesity as abnormal or excessive
accumulations of fat, raising risks such as insulin resistance, glucose intolerance, hypertension,
100211
Nov 2023
Rating
★ ★ ★ ★ ★ (85)
add_shopping_cart Buy Now
sleep apnea, diabetes mellitus, arthritis gall bladder diseases and certain cancers. With rising
rates of obesity prevalence comes an increased burden from chronic debilitating diseases
that impede daily function severely reducing lifespan significantly – this epidemic of disease
Trusted by more than 17382
impacts us all.
organizations globally
Hence, there is an increased need for effective obesity treatment solutions to reduce the risk of
chronic disorders. Several therapy solutions are available for weight loss, such as exercise,
medications, invasive surgery, and devices. Obesity involves several genetic and physiological
factors responsible for the growth of the disease.
Key Takeaways
Market Size & Growth: Obesity Treatment Market size is expected to be worth around USD
58.3 Billion by 2033 from USD 14.9 Billion in 2023, growing at a CAGR of 14.6%
Surgery Type Analysis: The Roux-en-Y Gastric Bypass held the 25.9% in the obesity
treatment market.
Drug Type Analysis: Appetite suppressants segment dominating 36.4% market share in
2023.
End-Use Analysis: The hospital segment is dominating of 63.2% market share in the
obesity treatment market.
Regional Analysis: North America is dominating 42.7% share And holding USD 6.016
Billion in the obesity treatment market.
Approaches to Treating Obesity: Obesity treatment may employ several strategies,
including lifestyle modifications, medications and surgical interventions. The right choice
depends on both severity of obesity as well as individual considerations regarding
individual health needs and considerations.
Technological Adoption: As technology becomes an ever-more integral component of
obesity treatment, innovations like digital solutions, apps and wearable devices play a
pivotal role in monitoring and optimizing treatment efficacy.
Surgery Type Analysis
Roux-en-Y Gastric Bypass Held the most significant Shares in the Obesity Treatment Market
Based on surgery type, the market is segmented into adjusting gastric banding,
biliopancreatic diversion with duodenal switch, sleeve gastrectomy, roux-en-y gastric bypass,
and other surgery types. The Roux-en-Y Gastric Bypass held the 25.9% in the obesity treatment
market. The Roux-en-Y Gastric Bypass is one of the best solutions for losing weight or average
weight loss around the year.
Several government activities about the problems, such as technological development in the
healthcare sector, overweight, and easy availability of weight gain treatments, drive the
obesity treatment market. Also, introducing advanced technologies with minimum side effects
is the major focus of many companies. The researchers have been trying to renew white blood
cells to work more like the brown fat cells. If this idea succeeds, they can efficiently treat the
body’s fat-burning process.
Drug Type Analysis
Appetite Suppressants Held the Largest Shares in Drug Type Segment
Based on drug type, the market is segmented into combination drugs, appetite suppressants,
malabsorption, and satiety drugs. Appetite suppressants segment dominating 36.4% market
share in 2023. Appetite suppressants work by suppressing hunger; it helps to reduce weight
loss by reducing food consumption. Doctors recommend Orlistat drug for weight loss.
The doctors refer the drug only when in cases in which patients fail to lose weight even after
taking proper diet and physical exercise, and their weight threatens the patients’ health. There
is no substitute for lifestyle changes, even orlistat also. The orlistat shows some side effects
involving gastrointestinal problems, headaches, and irregular urination. Patients can lose
weight by taking a low-calorie diet with proper drug treatment.
End-Use Analysis
The hospital segment Dominates the Obesity Treatment Market.
Based on end-user, the market is segmented into clinics and hospitals. The hospital segment
is dominating of 63.2% market share in the obesity treatment market. Due to healthcare
facilities and infrastructure, advanced technology in the hospitals.
The increase in obese patients and increased demand for advanced treatment in the
presence of skilled professionals will help expand this segment. Furthermore, due to an
increase in patient visits with innovative research in this sector, there is an increase in the
growth of the obesity treatment market during the forecast period.
Key Market Segments
Surgery Type
Adjustable gastric banding
Roux-en-Y gastric bypass
Sleeve gastrectomy
Biliopancreatic diversion with duodenal switch
Endoscopic procedures
Others
Drug Type
Appetite suppressants
Combination drugs
Malabsorption drugs
Satiety drugs
End-Use
Hospitals
Clinics
Drivers
Changing Lifestyles and Diets, Peoples Drive the Growth of the Obesity Treatment Market
Many peoples change their lifestyle, which involves sleeping less, eating an unhealthy diet, and
drinking such factors helps to increase obesity. It is a significant factor driving the market
growth during the forecast period. The increase in government activities to detect the
problems of lower weight people and increase in advanced development and effective weight
control therapies. UK government announced new rules and regulations to control obesity, and
the Better Health company encourages people to lose weight to improve their health.
Motivating individuals for better health is one of the best goals; it will help to drive the obesity
treatment market growth. The advanced development in technologies and therapies such
things helps the expansion of the obesity treatment market. Due to medical organization and
their efforts obesity treatment market is estimated to grow during the forecast period.
The obesity treatment market is significantly growing by increasing awareness of sickness in
all developing countries. Increasing weight control programs and creating a website that gives
proper guidance to people such activities create awareness about the risk of being
overweight such factors drive the growth of the obesity treatment market.
Restraints
Expensive Treatments and Drugs Restrict the Growth of Market
The expensive drugs and treatments may restrict the growth of the obesity treatment market.
The weight loss treatment is not refunded in developing countries. Obesity treatment is a timeconsuming process that will hamper market growth. The concerns about obesity drug
treatment are the reason for conducting clinical trials. In addition, the adverse effects of the
weight management drugs, such as diarrhea and nausea and lack of combination
treatments, may restrict the market growth.
Opportunity
Advanced Treatments and Awareness Programs in Obesity Treatment Market
The expanding healthcare sectors in several emerging economic areas contribute to an
increase in the global obesity treatment market. The growth in the geriatric population, rise in
patient numbers, and growing awareness among individuals are helping expand healthcare
industries worldwide. The expansion of the healthcare sector is significantly impacted by
increasing awareness about sickness in developing regions.
Increasing weight control activities, all plications which help to direct right track to perform an
individual’s regular activity and stop being overweight which is very dangerous for the health.
The increase in investment in this sector is anticipated to provide market growth opportunities
through an increase in the number of applications of the obesity treatment market in
healthcare industries; increasing investment in this market is expected to offer growth
opportunities.
Trends
Use of Orlistat for the Treatment of Obesity
Obesity poses a considerable challenge for both middle and low-income economies;
according to WHO, being overweight is associated with several diseases, leading to higher
mortality rates than undernutrition. The high prevalence of chronic diseases, diabetes,
hypertension, and orthopedic disease is associated with being overweight. They are also
choosing a poor lifestyle, unhealthy food, and lack of physical activity responsible for the
weight gain.
Appetite suppressants are the type of supplements that work by reducing the appetite with
weight loss and decreasing food consumption. Individuals use therapies to reduce highcalorie diets. Orlistat does not help with the changing lifestyle. It shows various side effects,
such as gastrointestinal symptoms and headaches. Also, the gastric band is used by doctors
to make the stomach smaller. After the operation, patients cannot consume more food in
sitting, which considerably helps to reduce food intake.
Regional Analysis
North America is Most Dominating Region During the Forecast Period
North America is dominating 42.7 share And holding USD 6.016 Billion in the obesity treatment
market. Easy accessibility of increasing investments in advanced technology and an increase
in R&D activities are the main factors that help expand the obesity treatment market. The
increasing prevalence of chronic diseases and obesity in people will help the growth of these
regions.
Also, there is increasing awareness about healthy diet and exercise for good health, rising
facilities for exercise, and an increase in disposable income in this region. Asia Pacific is also
increasing their focus on obesity treatment. Asia Pacific provides health care facilities and
infrastructure, raising awareness about the harmful effects of obesity and increasing medical
tourism; all factors help to boost the obesity market growth in these regions.
Asia Pacific offers tremendous potential to the key market players to expand the market. Also,
these regions give the market players a chance to launch their effective products. Increase in
customer base and manufacturers quickly expanding their business in this sector. Brazil is
expected to provide an attractive market potential for weight loss and management of diet for
better health during the projection period due to the increase in the prevalence of obesity in
these regions.
Key Regions
North America
The US
Canada
Mexico
Western Europe
Germany
France
The UK
Spain
Italy
Portugal
Ireland
Austria
Switzerland
Benelux
Nordic
Rest of Western Europe
Eastern Europe
Russia
Poland
The Czech Republic
Greece
Rest of Eastern Europe
APAC
China
Japan
South Korea
India
Australia & New Zealand
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Rest of APAC
Latin America
Brazil
Colombia
Chile
Argentina
Costa Rica
Rest of Latin America
Middle East & Africa
Algeria
Egypt
Israel
Kuwait
Nigeria
Saudi Arabia
South Africa
Turkey
United Arab Emirates
Rest of MEA
Key Players Analysis
Emerging key players are focused on various strategic policies to develop their respective
businesses in foreign markets. As a result, several obesity treatment market companies are
expanding their operations and R&D facilities.
Furthermore, businesses in the obesity treatment market are developing new products and
portfolio expansion strategies through investments, mergers, and acquisitions. In addition,
several key players are now focusing on different marketing strategies, such as spreading
awareness about natural ingredients and boosting the target products’ growth.
With many local and regional players, the market for global obesity treatment is fragmented.
Market players are subject to intense competition from top players, particularly those with
strong brand recognition and high distribution networks. As a result, companies have gained
various expansion strategies, such as partnerships and product launches, to stay on top of the
market.
Market Key Players
Listed below are some of the most prominent obesity treatment market players.
AbbVie Incorporation,
Medtronic PLC
F. Hoffmann-La Roche, Ltd.
Apollo Endosurgery, Inc.
Arena Pharmaceuticals, Incorporation,
Brunswick Corporation, C.H.
Boehringer Sohn AG & Ko. KG,
Herbalife Ltd.
Johnson & Johnson Services, Inc.
Other Key Players
Recent Developments
In February 2022: Pfizer’s Research on an oral diabetes drug called The glucagon-like
peptide-1 receptor as an oral diabetes drug suggested by Pfizer research that this drug
can support managing type-2 diabetes and benefit weight loss since obesity is
frequently associated with type 2 diabetes.
In November 2021: Novo Nordisk declared that the European regulator, the Agency for
Medicinal Products for Human Usage, has approved a favorable opinion and suggested
marketing authorization of Wegovy for Chronic Weight management in obese adults.
Report Scope
Report Features
Description
Market Value (2023)
USD 14.9 Billion
Forecast Revenue
USD 58.3 Billion
(2033)
CAGR (2024-2033)
14.6%
Base Year for Estimation
2023
Historic Period
2018-2022
Forecast Period
2024-2033
Report Coverage
Revenue Forecast, Market Dynamics, Competitive Landscape, Recent
Developments
Segments Covered
By Surgery Type-(Adjustable gastric banding, Roux-en-Y gastric
bypass, Sleeve gastrectomy, Biliopancreatic diversion with duodenal
switch, Endoscopic procedures, Others);By Drug Type-(Appetite
suppressants, Combination drugs, Malabsorption drugs, Satiety
drugs); End-Use-(By Hospitals, Clinics)
Regional Analysis
North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy,
Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India,
Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South
America;MEA-GCC, South Africa, Israel, Rest of MEA
Competitive Landscape
AbbVie Incorporation,, Medtronic PLC, F. Hoffmann-La Roche, Ltd.,
Apollo Endosurgery, Inc., Arena Pharmaceuticals, Incorporation,,
Brunswick Corporation, C.H., Boehringer Sohn AG & Ko. KG,, Herbalife
Ltd., Johnson & Johnson Services, Inc., Other Key Players
Customization Scope
Customization for segments, region/country-level will be provided.
Moreover, additional customization can be done based on the
requirements.
Purchase Options
We have three licenses to opt for: Single User License, Multi-User
License (Up to 5 Users), Corporate Use License (Unlimited User and
Printable PDF)
Obesity Treatment Market
Published date: Nov 2023
add_shopping_cart Buy Now
get_app Download Sample
Related Reports
Autologous Cell Therapy Market
Legal Marijuana Market
Legal Cannabis Market
Regenerative Medicine Market
Alzheimer’s disease therapeutics Market
Monoclonal Antibodies Market
Orally Disintegrating Tablet Market
Atorvastatin Calcium Market
Ampoules and Blister Packaging Market
Menkes Syndrome Market
Our Clients
SINGLE USER
MULTI USER
$6,000
$8,000
CORPORATE USER
$10,000
$3,999
$5,999
$6,999
USD / PER UNIT
USD / PER UNIT
USD / PER UNIT
SAVE 24%
SAVE 28%
SAVE 32%
No
up to 10 hrs work
up to 30 hrs work
1 User
2-5 User
Unlimited
up to 20 hrs
up to 40 hrs
up to 50 hrs
Up to 20% off on next purchase
Up to 25% off on next purchase
Up to 30% off on next purchase
Buy Now ($ 3,999)
Buy Now ($ 5,999)
Buy Now ($ 6,999)
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization
Accessibility
Analyst Support
Benefit
Lexington Avenue, Suite
location_on 420
300 New York City, NY 10170,
United States
phone +1 718 874 1545 (International)
phone +91 78878 22626 (Asia)
email inquiry@market.us
Find Help
Explore
Contact Us
About Us
How to Order
All Reports
Legal
Privacy Policy
Refund Policy
Frequently Asked Questions
Terms and Conditions
© 2025 Market.Us. All Rights Reserved.
All Sectors
Infographics
Statistics and Facts
Companies
Secured Payment Options